Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino et al

New treatments in myositis on the horizon.

EULAR rheumatology open·2026

Plasma Proteome Reflects Tissue Damage and Clinical Manifestations in Patients With Inflammatory Myopathies.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Identification of genetic variants associated with idiopathic inflammatory myopathies via cross-trait analysis with B cell lymphomas.

HGG advances·2026

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Communications medicine·2026

Identification of Novel Risk Loci for Common B-Cell Lymphoma Subtypes Through Cross-Trait Analysis with Idiopathic Inflammatory Myopathies.

Cancers·2026

Elevated sST2 associates with cardiac involvement and declines after treatment in newly diagnosed patients with idiopathic inflammatory myopathies.

Arthritis research & therapy·2026

MRI and ultrasound predictors of progression to inflammatory arthritis in anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis: a prospective cohort study.

Annals of the rheumatic diseases·2026

Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

Annals of the rheumatic diseases·2026

Sequential disease activity assessment for predicting future treatment trajectories in patients with rheumatoid arthritis treated with JAK inhibitors: a group-based trajectory and landmark analysis.

Annals of the rheumatic diseases·2026

A new humanised TCR transgenic mouse model to study T cells reactive to citrullinated tenascin C, a relevant autoantigen in rheumatoid arthritis.

Annals of the rheumatic diseases·2026

Automated detection of active and structural MRI lesions in the sacroiliac joints in axial spondyloarthritis: training and validation across 3 phase III clinical trial datasets.

Annals of the rheumatic diseases·2026

Performance of a triage approach for identification of patients with inflammatory rheumatic and musculoskeletal diseases among rheumatology referrals.

Annals of the rheumatic diseases·2026

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Frontiers in medicine·2026

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

BMC gastroenterology·2026

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

MedScience·2026

Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

Journal of neurointerventional surgery·2026

sFgl2‑enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity.

Colloids and surfaces. B, Biointerfaces·2026

Patterns and outcomes of emergency department visits by patients receiving immune checkpoint inhibitors: a single-center, retrospective study.

Cancer treatment and research communications·2026

Related Experiment Videos

Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino et al

Related Concept Videos

New treatments in myositis on the horizon.

Plasma Proteome Reflects Tissue Damage and Clinical Manifestations in Patients With Inflammatory Myopathies.

Identification of genetic variants associated with idiopathic inflammatory myopathies via cross-trait analysis with B cell lymphomas.

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Identification of Novel Risk Loci for Common B-Cell Lymphoma Subtypes Through Cross-Trait Analysis with Idiopathic Inflammatory Myopathies.

Elevated sST2 associates with cardiac involvement and declines after treatment in newly diagnosed patients with idiopathic inflammatory myopathies.

MRI and ultrasound predictors of progression to inflammatory arthritis in anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis: a prospective cohort study.

Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

Sequential disease activity assessment for predicting future treatment trajectories in patients with rheumatoid arthritis treated with JAK inhibitors: a group-based trajectory and landmark analysis.

A new humanised TCR transgenic mouse model to study T cells reactive to citrullinated tenascin C, a relevant autoantigen in rheumatoid arthritis.

Automated detection of active and structural MRI lesions in the sacroiliac joints in axial spondyloarthritis: training and validation across 3 phase III clinical trial datasets.

Performance of a triage approach for identification of patients with inflammatory rheumatic and musculoskeletal diseases among rheumatology referrals.

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

sFgl2‑enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity.

Patterns and outcomes of emergency department visits by patients receiving immune checkpoint inhibitors: a single-center, retrospective study.

Related Experiment Videos

Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino et al

Related Concept Videos

Related Articles